Modulation of Macrophage Phenotype by

Soluble Product(s) Released from Neutrophils

This information is current as
of December 11, 2017.
Jean M. Daley, Jonathan S. Reichner, Eric J. Mahoney,
Laura Manfield, William L. Henry, Jr., Balduino
Mastrofrancesco and Jorge E. Albina
J Immunol 2005; 174:2265-2272; ;
doi: 10.4049/jimmunol.174.4.2265
http://www.jimmunol.org/content/174/4/2265

Downloaded from http://www.jimmunol.org/ by guest on December 11, 2017

Why The JI?
Rapid Reviews! 30 days* from submission to initial decision
No Triage! Every submission reviewed by practicing scientists
Speedy Publication! 4 weeks from acceptance to publication
*average

References This article cites 25 articles, 11 of which you can access for free at:
http://www.jimmunol.org/content/174/4/2265.full#ref-list-1
Subscription Information about subscribing to The Journal of Immunology is online at:
http://jimmunol.org/subscription
Permissions Submit copyright permission requests at:
http://www.aai.org/About/Publications/JI/copyright.html
Email Alerts Receive free email-alerts when new articles cite this article. Sign up at:
http://jimmunol.org/alerts

The Journal of Immunology is published twice each month by

The American Association of Immunologists, Inc.,
1451 Rockville Pike, Suite 650, Rockville, MD 20852
Copyright 2005 by The American Association of
Immunologists All rights reserved.
Print ISSN: 0022-1767 Online ISSN: 1550-6606.
 The Journal of Immunology

Modulation of Macrophage Phenotype by Soluble Product(s)

Released from Neutrophils1

Jean M. Daley,2 Jonathan S. Reichner, Eric J. Mahoney, Laura Manfield, William L. Henry, Jr.,
Balduino Mastrofrancesco, and Jorge E. Albina
The regulation of macrophage phenotype by neutrophils was studied in the s.c. polyvinyl alcohol sponge wound model in mice
made neutropenic by anti-Gr-1 Ab, as well as in cell culture. Wounds in neutropenic mice contained 100-fold fewer neutrophils
than those in nonneutropenic controls 1 day after sponge implantation. Wound fluids from neutropenic mice contained 68% more
TNF-, 168% more IL-6, and 61% less TGF-1 than those from controls. Wound fluid IL-10 was not different between the two
groups, and IL-4 was not detected. Intracellular TNF- staining was greater in cells isolated from neutropenic wounds than in
those from control wounds. The hypothesis that wound neutrophil products modulate macrophage phenotype was tested in
Transwell cocultures of LPS-stimulated J774A.1 macrophages and day 1 wound cells (84% neutrophils/15% macrophages).

Downloaded from http://www.jimmunol.org/ by guest on December 11, 2017

Overnight cocultures accumulated 60% less TNF- and IL-6 than cultures of J774A.1 alone. The suppression of cytokine release
was mediated by a soluble factor(s), because culture supernatants from wound cells inhibited TNF- and IL-6 release from
LPS-stimulated J774A.1 cells. Culture supernatants from purified wound neutrophils equally suppressed TNF- release from
LPS-stimulated J774A.1 cells. Wound cell supernatants also suppressed TNF- and superoxide release from murine peritoneal
macrophages. The TNF- inhibitory factor has a molecular mass <3000 Da and is neither PGE2 nor adenosine. The present
findings confirm a role for neutrophils in the regulation of innate immune responses through modulation of macrophage
phenotype. The Journal of Immunology, 2005, 174: 22652272.

N eutrophils are the first blood-borne nucleated cells to
infiltrate sites of injury or infection, where they produce
multiple effector molecules, including reactive oxygen
and nitrogen intermediates, proteolytic enzymes, and cytokines.
The anti-infectious capacity of neutrophils provides obvious func-
tional advantage to their recruitment into infected tissue. Neutro-
phils, however, also accumulate in large numbers at sites of sterile
inflammation, such as uninfected wounds, myocardial and cerebral
infarctions, and fractures where, in the absence of infectious chal-
lenge, their role in the inflammatory response is less readily
apparent.
Experiments reported in this study were initially designed to
define the contribution of neutrophils to the cytokine profile of an
acute sterile inflammatory site, such as that provided by the poly-
vinyl alcohol (PVA)3 sponge wound model. The findings demon-
strated that neutrophil depletion results in increased proinflamma-
tory cytokine concentrations in early tissue inflammation. This
finding suggested that neutrophils produce a factor(s) that inhibits
the release of proinflammatory cytokines by macrophages. The
Department of Surgery, Division of Surgical Research, Rhode Island Hospital and
Brown Medical School, Providence, RI 02903
Received for publication April 27, 2004. Accepted for publication December 1, 2004.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked advertisement in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
1
This work was funded by National Institutes of Health Grants GM42859 (to J.E.A.)
and GM66194 (to J.S.R.) and by funds allocated to the Department of Surgery by
Rhode Island Hospital, a Lifespan partner. J.M.D. was supported by a National In-
stitutes of Health Supplement to Promote Reentry into Biomedical and Behavioral
Research Careers. E.J.M. was supported by the Carter Family Charitable Trust
(Armand D. Versaci Research Scholar in Surgical Sciences Award).
2
Address correspondence and reprint requests to Dr. J. M. Daley, Division of Sur-
gical Research, Rhode Island Hospital, NAB 214, 593 Eddy Street, Providence, RI
02903. E-mail address: jdaley@lifespan.org
3
Abbreviations used in this paper: PVA, polyvinyl alcohol; CM, complete medium.
results supported and extended the predictions of this hypothesis
by demonstrating that wound neutrophils produce a soluble fac-
tor(s) that suppresses LPS-mediated activation of a macrophage
cell line and primary peritoneal macrophages. The present results
thus reveal an additional capacity of neutrophils in inflammation,
namely, the ability of these cells to modulate macrophage inflam-
matory phenotype.
Materials and Methods
Animals
B6D2F1 male mice (Taconic Farms), 8 12 wk of age, were housed at the
Central Research Facilities of Rhode Island Hospital and fed mouse chow
and water ad libitum. Mice were certified free of common pathogens by the
supplier and were monitored by Brown University/Rhode Island Hospital
veterinary personnel. Animal protocols were approved by the animal care
committee at Rhode Island Hospital.
PVA sponge wound model
Mice were anesthetized with pentobarbital (50 mg/kg i.p.; Abbott Labo-
ratories). Five PVA sponges (PVA Unlimited), measuring 1 1 0.6 cm,
were inserted into individual s.c. pockets through a midline dorsal incision
under sterile conditions, and the skin was closed with clips (1). Mice were
euthanized by CO2 asphyxiation, and the sponges were removed under
sterile conditions. Culture of randomly selected PVA sponges at the time
of removal confirmed sterility in this experimental model. Wound cells
were isolated by rapid repeated compression of sponges in a Stomacher
(Tekmar). When necessary, cells were subjected to hypotonic lysis of
erythrocytes, followed by reconstitution in PBS (Invitrogen Life Technol-
ogies). Viable cells were identified by trypan blue exclusion and were
counted using a hemocytometer; viability was 95%. Differential cell
counts were performed on Hema-3 (Biochemical Sciences)-stained Cyto-
spins (Shandon), and cell phenotype was confirmed by flow cytometry, as
described below. Extracellular fluid from the PVA sponges (wound fluid)
was obtained by centrifugation (400 g for 5 min) of two or three sponges
in the barrel of a syringe that was seated in a sterile tube. Wound fluid was
stored at 80C until analysis.

Copyright 2005 by The American Association of Immunologists, Inc. 0022-1767/05/$02.00

2266 NEUTROPHIL PRODUCT(S) MODULATE MACROPHAGE PHENOTYPE
Induction of neutropenia
Anti-mouse Gr-1 mAb (RB6.8C5 hybridoma originally produced by R. L.
Coffman, DNAX Research Institute) was produced under serum-free con-
ditions using a bioreactor (Cell Pharm Micro Mouse; UniSyn Technolo-
gies). Mice were rendered neutropenic by a single i.p. injection of 0.5 mg
of anti-Gr-1 Ab 3 days before PVA sponge insertion. Control animals were
injected i.p. with an equal volume of normal saline or with 0.5 mg of rat
IgG (Rockland Immunochemicals).
Circulating leukocyte counts
Heparinized blood was obtained from the lateral tail vein or the inferior
vena cava. Leukocyte count was determined using a hemocytometer after
dilution and erythrocyte lysis with 0.01% crystal violet in 3% acetic acid.
Differential cell counts were performed on Hema-3 stained blood smears.
Purification of neutrophils from the wound cell suspension
Wound cells were isolated 1 day after PVA sponge insertion, suspended in
biotin-free FcR-blocking agent (Accurate Chemical & Scientific) at 0.3
ml/106 cells, washed, and incubated with biotin-conjugated Ab directed
against the macrophage cell surface Ag F4/80 (1 g/106 cells; Caltag Lab-
oratories). Cells were washed in PBS and incubated with MACS Anti-
Biotin MicroBeads (Miltenyi Biotec) according to the manufacturers rec-
ommendations, and macrophages were depleted using the MiniMACS
magnetic cell separator (Miltenyi Biotec). The resulting cell suspension
was 96% neutrophils by light microscopy.
Cell culture
All cell cultures were performed in complete medium (CM; RPMI 1640
(Invitrogen Life Technologies) supplemented with 10 mM MOPS, 5
105 M 2-ME, 100 U/ml penicillin-streptomycin, and 1% FBS (HyClone))
unless noted otherwise. The murine macrophage cell line J774A.1 was
obtained from American Type Culture Collection. Murine resident perito-
neal macrophages were obtained by peritoneal lavage with HBSS and 1%
FBS. Thioglycolate-elicited peritoneal macrophages were harvested 4 days
after i.p. injection of 3 ml of 3% Brewer modified thioglycolate medium
(BD Biosciences). J774A.1 macrophages or peritoneal macrophages were
allowed to adhere to tissue culture-treated plastic for 2 h, and nonadherent
cells were removed before initiation of experiments.
Three culture formats were used for coculture experiments: 1) J774A.1
cells, 5 105 in 1 ml of CM; 2) wound cells, 2.5 106 in 1 ml of CM;
and 3) cocultures in Transwell plates (0.4-m pore size; Costar) containing
5 105 J774A.1 cells in the lower chamber and 2.5 106 wound cells in
the upper chamber in a total volume of 1 ml of CM. LPS (Escherichia coli
serotype 055:B5, Sigma-Aldrich; 0.1 g/ml) was added 1 h after the ini-
tiation of all cultures. Where noted, indomethacin (Sigma-Aldrich) or NS-
398 (Cayman Chemicals) was added at the start of cell incubation.
J774A.1 cells or peritoneal macrophages were also cultured with super-
natants conditioned by day 1 wound cells. The wound cell-conditioned
supernatant was generated by isolating wound cells from PVA sponges 1
day after insertion and culturing these cells in CM at 2.5 106/ml for 24 h.
Cells were then removed from the medium by centrifugation, and the su-
pernatant was stored at 80C. Supernatants conditioned by purified
wound neutrophils were generated in similar manner. J774A.1 cells (1
105) or primary peritoneal macrophages (3 105) were incubated in 200
l of CM or a 1/1 (v/v) dilution of wound cell-conditioned supernatant in
CM for 1 h before addition of LPS, then cultured for an additional 24 h.
Wound cell-conditioned supernatant was fractionated using Amicon Cen-
triplus YM-3 centrifugal filter devices (Millipore). When indicated, wound
cell-conditioned supernatant or an equal volume of CM was treated with
adenosine deaminase (type X from bovine spleen; Sigma-Aldrich) at 0.02
U/ml for 20 min at 25C, and adenosine deaminase was removed, or not,
using a Centricon-10 concentrator (Millipore) before addition of the treated
supernatant to cell cultures. Indomethacin, NS-398, AH6809 (Cayman
Chemicals), L161982 (gift from Dr. R. Young, Merck Frosst Canada), or
8 phenyl-theophylline (Sigma-Aldrich) was added to cell cultures where
noted.
Conditioned culture supernatants were also prepared from splenic lym-
phocytes. Splenocytes were obtained by mechanical dissociation of spleens
and elimination of fibrous tissue using wire mesh. Erythrocytes were re-
moved by hypotonic lysis; macrophages and dendritic cells were depleted
by adherence to plastic for 2 h. Supernatants were prepared from the re-
sulting cell suspension (90% lymphocytes, 4% monocytes, and 4% neu-
trophils) by culture at 2.5 106/ml for 24 h. Conditioned supernatants
were also prepared from murine L929 fibroblasts and from fibroblasts ob-
tained from a murine wound by culture at a density of 5 105/ml for 24 h.
Cells were removed by centrifugation, and the supernatants were used as
described above.
Macrophage viability was assessed after 24 h of incubation by trypan
blue exclusion, reduction of MTT (Sigma-Aldrich) (2), and release of lac-
tate dehydrogenase (3). Protein synthesis was determined by measuring the
24-h incorporation of L-[ring-2,6-N-3H]phenylalanine into TCA-precipita-
ble protein. When indicated, cells were lysed in buffer containing 0.01 M
Tris, 0.15 M NaCl, and 0.5% Igepal CA 630 (Sigma-Aldrich) with Com-
plete (Roche) protease inhibitor.
Cell staining and flow cytometry
Wound cells were isolated from neutropenic or control animals 1 day after
sponge insertion and pooled. Abs used for cell staining and flow cytometry
were obtained from BD Biosciences unless noted otherwise.
Surface Ag staining. Erythrocytes were removed from the wound cell
suspension by hypotonic lysis. Cells were incubated with FcR-blocking
agent (Accurate Chemical & Scientific), washed in PBS with 1% FBS, and
incubated with predetermined optimal concentrations of fluorochrome-
conjugated Abs to B220 and IgM (for B cells), CD3 (for T cells), or the
appropriate isotype control Abs.
Intracellular Ag staining. Erythrocytes were removed from the wound
Downloaded from http://www.jimmunol.org/ by guest on December 11, 2017
cell suspension by hypotonic lysis. Cells were incubated with FcR-block-
ing agent (Accurate Chemical & Scientific), washed in PBS with 1% FBS,
fixed in paraformaldehyde with saponin (Cytofix/Cytoperm; BD Bio-
sciences) according to the manufacturers recommendations, washed in
Permwash (BD Biosciences), and incubated with a predetermined optimal
concentration of fluorochrome-conjugated Ab directed against the intracel-
lular macrophage Ag macrosialin (anti-CD68; Serotec) or the appropriate
isotype control Ab.
Intracellular cytokine staining. Cells were incubated (106 cells/ml) in
CM for 6 h with brefeldin A (Golgiplug; BD Biosciences) at 1 l/106 cells
and stained for intracellular Ag as described above, using anti-CD68, anti-
TNF-, and/or the appropriate isotype control Abs.
Cells were analyzed and sorted using a FACSort and CellQuest software
(BD Biosciences). Cells were stained with propidium iodide after sorting,
and nuclear morphology was determined by light microscopy.
Assays
TNF- (BioSource), IL-6 (BD Biosciences), TGF-1 (R&D Systems),
IL-4, and IL-10 (4) were assayed by ELISA. PGE2 was quantified by en-
zyme immunoassay (Cayman Chemical). ATP, ADP, AMP, and adenosine
were assayed by HPLC (5) with a limit of detection of 1 M. TNF-
bioactivity was determined by lysis of actinomycin D (Sigma-Aldrich)-
treated L929 murine fibroblasts (NCTC clone 929; American Type Culture
Collection) (6), using a recombinant murine TNF- standard (R&D Sys-
tems). Superoxide release was measured from the reduction of ferricyto-
chrome c (Sigma-Aldrich) after cell stimulation with 200 nM PMA (LC
Services) over 90 min (7).
Data presentation and analysis
Data reported are the mean 1 SD unless otherwise noted. Results from
cell culture experiments are from triplicate wells in a representative ex-
periment. Statistical analysis was performed using Students unpaired t
test, Mann-Whitney U test, or ANOVA with Newman-Keuls test, as
appropriate.
Results
Characterization of the cellular infiltrate in the PVA sponge
wound model
The leukocytic infiltration of the wound increased over the first 7
days after PVA sponge insertion (Fig. 1A). Day 1 wound cells
were 84 4% neutrophils, 15 4% macrophages, 1% lym-
phocytes, and 1% eosinophils in six experiments with at least
five animals per experiment (mean SEM). Neutrophils remained
the most abundant cell type through at least 3 days after wounding
(Fig. 1B). Macrophages constituted 52% of the cells isolated from
the wound 7 days after wounding. All subsequent experiments
using wound cells or wound fluids were performed using cells or
fluids isolated 1 day after PVA sponge insertion.
The Journal of Immunology
FIGURE 1. Characterization of the cellular infiltrate in the PVA sponge
wound. PVA sponges were inserted as described in Materials and Meth-
ods, and six animals each were euthanized at 1, 3, and 7 days after sponge
insertion. Wound cells were isolated, identified, and counted as described
in Materials and Methods. A, Wound cell count per animal. Counts differed
at all time points (p 0.05, by ANOVA and Newman-Keuls test). B,
Differential cell count. f, neutrophils; _, macrophages.
Effect of anti-Gr-1 Ab on circulating and wound leukocyte
counts
Intraperitoneal injection of 0.5 mg of mAb directed against the
neutrophil surface Ag Gr-1 reduced neutrophils from 13.3 1.5 to
1.4 1.0% of the total circulating leukocytes. Neutropenia per-
sisted throughout the time course of these experiments (4 days).
Differential blood lymphocyte and monocyte counts were not al-
tered by Ab treatment (data not shown).
The effect of anti-Gr-1 Ab on leukocyte infiltration of the
wounds was quite marked: wounds from neutropenic animals con-
tained 67-fold fewer total cells than controls, with 100-fold less
neutrophils and 10-fold less macrophages (Fig. 2).
Neutrophil depletion increases proinflammatory cytokines in
wound fluids
Table I shows the cytokine content of wound fluids from control
and neutropenic animals. Despite the decrease in the inflammatory
cell infiltrate, immunoreactive TNF- and IL-6 concentrations in
wound fluid from neutropenic animals were 68 and 168% higher,
respectively, than those from controls, whereas TGF-1 concen-
FIGURE 2. Anti-Gr-1 Ab depletes leukocyte populations in the PVA
sponge wound. Mice were injected i.p. with 0.5 mg of anti-Gr-1 Ab or an
equal volume of saline, and PVA sponges were inserted into control (n
6) and neutropenic (n 7) mice 3 days later. Wound cells were isolated 1
day after sponge insertion. The graph shows cell counts per animal (E) and
group means (). Neutropenic wounds had lower total cell, neutrophil, and
macrophage counts than control wounds (p 0.05, by Mann-Whitney U
test).
2267
Table I. Cytokine concentration in wound fluids: neutrophil depletion
selectively increases proinflammatory cytokinesa
Control Neutropenic
TNF- (pg/ml) 322 99 542 125
IL-6 (ng/ml) 22 14 59 19
TGF-1 (pg/ml) 1331 429 520 176
IL-10 (pg/ml) 116 38 108 32
IL-4 ND ND
a
Mice were injected i.p. with 0.5 mg of anti-Gr-1 Ab or saline, and PVA sponges
were inserted into neutropenic and control mice 3 days later. Wound fluids obtained
1 day after sponge insertion were assayed for cytokines as described in Materials and
Methods. The concentrations of TNF- and IL-6 in wound fluids from animals that
had been injected i.p. with 0.5 mg of rat IgG were not different from those in saline-
injected controls (data not shown). A minimum of six animals was tested in each
group. The table shows means one SD.
, p 0.05, Mann-Whitney U test.
trations were 61% lower. Wound fluid IL-10 concentrations were
not different between the two groups. IL-4 was below the limit of
Downloaded from http://www.jimmunol.org/ by guest on December 11, 2017
detection of the assay (10 pg/ml) in wound fluids from either
group.
The increases in proinflammatory cytokines in wound fluids
from neutropenic animals were independent of plasma cytokines.
Plasma TNF- concentrations at the time of sponge removal were
below the limit of detection of the assay (30 pg/ml) in both groups.
There was no difference in the plasma concentrations of IL-6 (con-
trol, 59 21 pg/ml; neutropenic, 48 14 pg/ml; p 0.05, by
Mann-Whitney U test). Neutropenic animals did not exhibit
obvious differences in the appearance of the surgical site or in
postoperative behavior compared with wounded control animals.
Cells from neutropenic wounds contain more TNF- than those
from control wounds
To determine the source of increased TNF- in the wound fluids of
neutropenic animals, cells were isolated from control and neutro-
penic wounds, cultured with brefeldin to inhibit intracellular cy-
tokine transport, then stained for intracellular TNF- and the in-
tracellular macrophage Ag CD68. The validity of CD68 staining
for the identification of wound macrophages was confirmed by
microscopic examination of the cells after FACS. In control ani-
mals, CD68high cells were 98.5% macrophages/mononuclear cells
and 1.5% polymorphonuclear leukocytes; CD68/low cells were
95.0% polymorphonuclear leukocytes (including bands) and 4.0%
macrophages/mononuclear cells. As will be discussed below, in
FIGURE 3. Intracellular TNF- staining in cells from control and neu-
tropenic wounds. Mice were injected i.p. with 0.5 mg of anti-Gr-1 Ab or
saline, and PVA sponges were inserted 3 days later. Wound cells isolated
1 day after sponge insertion were cultured with brefeldin A and stained for
intracellular TNF- and macrophage intracellular Ag CD68 as described in
Materials and Methods. MCF, mean channel fluorescence of the quadrant.
2268 NEUTROPHIL PRODUCT(S) MODULATE MACROPHAGE PHENOTYPE
FIGURE 4. Wound cells inhibit TNF- and IL-6 release by LPS-stim-
ulated J774A.1 macrophages. Wound cells were isolated from nonneutro-
penic mice 1 day after sponge insertion. Wound cells (2.5 106) or
J774A.1 cells (J774; 5 105) were cultured in 1 ml of CM. Transwell
cocultures (J774 and wound cells) contained 5 105 J774A.1 cells in the
lower chamber and 2.5 106 wound cells in the upper chamber in a total
volume of 1 ml. Cells were cultured with LPS (0.1 g/ml) for 24 h. Culture
supernatants were assayed for TNF- by ELISA (A), for TNF- bioactivity
by lysis of actinomycin-treated L929 cells (B), or for IL-6 by ELISA (C).
TNF- and IL-6 concentrations were lower in cocultures than in J774A.1
cells cultured alone (p 0.05, by Students unpaired t test).
neutropenic animals the CD68/low cells included a greater pro-
portion of mononuclear cells with morphologic characteristics of
monocytes, macrophages, and lymphocytes than those in controls.
The intensity of staining for TNF- was greater in CD68high
cells than in CD68/low cells in both neutropenic and control
animals (Fig. 3). Macrophages from neutropenic wounds stained
more intensely for TNF- than those from controls. The blood
FIGURE 5. Kinetics of TNF- release in J774A.1/wound cell cocul-
tures stimulated with LPS. Transwell cocultures of J774A.1 cells and day
1 wound cells were performed as described in Fig. 4. TNF- concentra-
tions were lower in cocultures than in J774A.1 cells cultured alone at 20
and 24 h (p 0.001, by two-factor ANOVA).
Downloaded from http://www.jimmunol.org/ by guest on December 11, 2017
leukocytes of control and neutropenic animals did not differ in
intracellular TNF- staining (data not shown).
The CD68/low cells from neutropenic wounds contained more
TNF- than those from control wounds. These CD68/lowTNF-
cells comprised 30% of the total cells from neutropenic animals.
Morphologic examination of these cells after FACS showed 59%
polymorphonuclear leukocytes and 41% mononuclear cells. In
control animals, the CD68/lowTNF- population of cells con-
stituted only 6.7% of the wound cell suspension and was com-
prised almost entirely of polymorphonuclear leukocytes (96%),
with the remaining 4% being mononuclear cells. The absolute
number of these CD68/lowTNF- mononuclear cells, as calcu-
lated from the respective total cellularity of control vs neutropenic
wounds, was actually higher in controls (4800/animal) than in neu-
tropenic wounds (2100/animal). These cells probably represent ex-
travasated monocytes, found in the laboratory to be CD68/low
(data not shown). In this regard it has been shown that CD68 Ag
expression is enhanced during macrophage recruitment (8).
Wound cells inhibit TNF- and IL-6 release by LPS-stimulated
J774A.1 macrophages
The hypothesis that wound cells, specifically wound neutrophils,
suppress cytokine release by macrophages in vivo was modeled
and tested in vitro. The murine macrophage cell line J774A.1 used
in these experiments was confirmed in the laboratory to exhibit
minimal release of TNF- in unstimulated culture and submaximal
cytokine release when stimulated with 0.1 g/ml LPS. J774A.1
macrophages were cultured in Transwells with or without day 1
wound cells (86% neutrophils) from nonneutropenic animals. Fig.
4A shows that supernatants from J774A.1/wound cell cocultures
contained 60% less immunoreactive TNF- than those from cul-
tures of J774A.1 cells alone. Results obtained by ELISA for
TNF- were confirmed in a bioassay (Fig. 4B). Similarly, super-
natants from J774A.1/wound cell cocultures contained 60% less
IL-6 than cultures of J774A.1 cells (Fig. 4C). Comparison of the
kinetics of TNF- release in cultures of LPS-stimulated J774A.1
cells vs those in J774A.1/wound cell cocultures showed that sup-
pression of TNF- release in cocultures was not evident until after
8 h of incubation (Fig. 5).
Culture supernatants conditioned by day 1 wound cells inhibit
TNF- and IL-6 release by LPS-stimulated J774A.1
macrophages
LPS-stimulated J774A.1 macrophages were also cultured in super-
natants previously conditioned by day 1 wound cells. As shown in
The Journal of Immunology 2269

Fig. 6, J774A.1 cultures containing wound cell-conditioned super-

natants accumulated 56% less TNF- and 60% less IL-6 at 24 h
than those in CM. The kinetics of TNF- release differed from
those in J774A.1/wound cell cocultures, because the inhibition of
TNF- release by wound cell supernatants was evident as early as
1 h after stimulation with LPS (Fig. 7). The suppression of TNF-
release was not due to cellular accumulation of the cytokine during
culture, because lysates from J774A.1 cells incubated with wound
cell-conditioned supernatants contained less TNF- than those in
CM (J774A.1 in supernatants, 133 6 pg/106 cells; J774A.1 in
CM, 147 6 pg/106 cells; p 0.05, by Students unpaired t test.).
IL-6 was not assayed in these samples because there is no cell-
associated form of the cytokine. The suppression of macrophage
FIGURE 7. Kinetics of TNF- release in LPS-stimulated J774A.1 mac-
TNF- release by wound cell supernatants was also evident in the rophages incubated with wound cell-conditioned supernatants. J774A.1
absence of LPS (J774A.1 cells in CM, 2.1 0.2 ng/ml; J774A.1 cells were cultured with LPS (0.1 g/ml), with or without wound cell-
in wound cell supernatants, 1.6 0.1 ng/ml; p 0.05, by Stu- conditioned supernatants, as described in Fig. 6. J774A.1 cultures with
dents unpaired t test.). wound cell-conditioned supernatants contained less TNF- than cultures in
To specifically assess the contribution of neutrophils to the CM at all time points (p 0.05, by two-factor ANOVA).
TNF--suppressive capacity of wound cells, LPS-stimulated

Downloaded from http://www.jimmunol.org/ by guest on December 11, 2017

J774A.1 macrophages were cultured in supernatants conditioned
by neutrophils purified from day 1 wound cells (96% neutrophils).
The neutrophil supernatant and the wound cell supernatant equally
suppressed TNF- release by J774A.1 macrophages (Fig. 6A).
Suppression of TNF- release from LPS-stimulated J774A.1
macrophages was not observed when supernatants were condi-
tioned by splenic lymphocytes or L929 murine fibroblasts.
(J774A.1 in CM, 94.2 14.1 ng/ml; J774A.1 in splenic lympho-
cyte-conditioned supernatant, 83.5 15.6 ng/ml; J774A.1 in
L929-conditioned supernatant, 114.4 13.8 ng/ml; p 0.05, by
ANOVA and Newman-Keuls test). Supernatants conditioned by
fibroblasts isolated from a murine wound suppressed TNF- re-
lease from LPS-stimulated J774A.1 cells (J774A.1 in mouse
wound-derived fibroblast-conditioned supernatant, 18.0 0.8 ng/
ml; p 0.05 vs J774A.1 in CM (above), by ANOVA and
Newman-Keuls test).
The suppression of proinflammatory cytokine release by wound
cell-conditioned supernatants did not result from cytotoxicity or
from nonspecific inhibition of protein synthesis. There was no dif-
ference between cells cultured in CM and those cultured in wound
cell supernatant with respect to cell viability at the end of culture,
as assessed by trypan blue exclusion, lactate dehydrogenase re-
lease, or reduction of MTT (Table II). Protein synthesis, as mea-
sured by incorporation of radiolabeled phenylalanine into protein,
was identical in both culture conditions.

Wound cell-conditioned supernatants inhibit release of TNF-

and production of superoxide by murine peritoneal macrophages
Wound cell-conditioned supernatants also inhibited LPS-stimu-
lated TNF- release from thioglycolate-elicited murine peritoneal
macrophages. As shown in Fig. 8A, macrophages incubated in
FIGURE 6. Culture supernatants from wound cells inhibit TNF- and
IL-6 release by LPS-stimulated J774A.1 macrophages. A, Wound cells
were isolated 1 day after PVA sponge insertion, and macrophages were
depleted from the wound cell suspension as described in Materials and Table II. Wound cell conditioned supernatants are not toxic to J774A.1
Methods. The unfractionated wound cells (86% neutrophils) or the purified macrophagesa
wound neutrophils (96% neutrophils) were cultured for 24 h at 2.5
106/ml. Supernatants from these cultures were diluted 1/1 with CM and Wound Cell
added to J774A.1 cells (5 105/ml) along with LPS (0.1 g/ml). The Conditioned
Complete Medium Supernatant
TNF- concentration of the culture supernatant was assayed by ELISA
after 24 h. J774A.1 cultures with either wound cell supernatant or wound Trypan blue exclusion (%) 95% 95%
neutrophil supernatant contained less TNF- than cultures in CM (p LDH in media (U/ml) 2.95 1.32 2.91 0.4
0.05, by ANOVA and Newman-Keuls test). B, J774A.1 cells were cultured MTT reduction (OD) 0.9 0.1 1.0 0.1
with LPS (0.1 g/ml), with or without wound cell-conditioned superna- [3H]Phenylalanine 3 protein (cpm) 3021 94 3432 298
tants. IL-6 was assayed by ELISA after 24-h culture. J774A.1 cultures with a
J774A.1 cells were cultured in CM or with wound cell supernatant as described
wound cell-conditioned supernatants contained less IL-6 than cultures in in the legend to Fig. 6. LDH, lactate dehydrogenase; [3H]phenylalanine 3 protein,
CM (p 0.01, by Students unpaired t test). incorporation of [3H]phenylalanine into protein.
2270 NEUTROPHIL PRODUCT(S) MODULATE MACROPHAGE PHENOTYPE

FIGURE 9. The 3000-Da fraction of wound cell supernatant inhibits

TNF- release by LPS-stimulated J774A.1 macrophages. J774A.1 cells
were cultured in CM () or wound cell supernatants (f) as described in
Fig. 6. The 3000-Da fraction of supernatant or CM was also diluted 1/1
with CM and added to J774.1 cultures. All cultures were treated with LPS
(0.1 g/ml). The TNF- concentration of the J774A.1 culture supernatant

Downloaded from http://www.jimmunol.org/ by guest on December 11, 2017

was assayed by ELISA after 24-h culture. Both the unfractionated and the
3000-Da fraction of wound cell supernatants inhibited TNF- release
compared with CM (p 0.01, by two-factor ANOVA).

indomethacin (10 M) reversed the inhibition of TNF- release in

FIGURE 8. Wound cell-conditioned supernatants inhibit TNF- release the cocultures (Fig. 10A). The effectiveness of cyclooxygenase
and superoxide production by LPS-stimulated primary murine peritoneal inhibitors was confirmed by measurement of PGE2 in the culture
macrophages. A, Thioglycolate-elicited peritoneal macrophages (3 105 medium (Fig. 10B).
in 200 l) were cultured with LPS (0.1 g/ml) with or without wound
cell-conditioned supernatants, as described in Fig. 6. TNF- was assayed
by ELISA after 24-h culture. Macrophages cultured with wound cell su-
pernatants released less TNF- than those cultured in CM (p 0.01, by
Students unpaired t test). B, Resident peritoneal macrophages (3 105 in
200 l) purified by overnight adherence were cultured with or without
wound cell-conditioned supernatants at varying doses of LPS. Macrophage
superoxide production was assayed after 24-h culture. Macrophages cul-
tured with wound cell-conditioned supernatants (f) produced less super-
oxide than those in CM (; p 0.05, by two-factor ANOVA).

wound cell supernatants released 71% less TNF- than those cul-
tured in CM. Resident peritoneal macrophages cultured in wound
cell supernatants also produced less superoxide after PMA stimu-
lation than those cultured in CM at all tested LPS concentrations
(Fig. 8B).

Partial characterization of the neutrophil-derived factor(s) that

inhibits proinflammatory cytokine release from J774A.1
macrophages
The neutrophil-derived factor(s) that inhibits proinflammatory cy-
tokine release by LPS-stimulated J774A.1 macrophages is resistant
to freezing and thawing and has a molecular mass 3000 Da. Fig.
9 shows that the 3000-Da filtrates of wound cell-conditioned
supernatants inhibited TNF- release by LPS-stimulated J774A.1
macrophages similar to unfractionated supernatants. IL-6 release
was also inhibited by the 3000-Da fraction of wound cell-con-
ditioned supernatants (J774A.1 in CM, 19.5 1.4 ng/ml; J774A.1
in supernatants, 11.4 0.7 ng/ml; p 0.01, by Students unpaired
t test). FIGURE 10. Effect of cyclooxygenase inhibitors on wound neutrophil in-
hibition of TNF- release by LPS-stimulated J774A.1 macrophages. J774A.1
PGE2 (9) and adenosine (10 13) have been shown to suppress
cells were cultured alone or with day 1 wound cells in Transwells as described
macrophage TNF- production and meet the criteria of stability to
in Fig. 4. NS-398 (10 M) or indomethacin (10 M) was added to cultures 1 h
freezing/thawing and molecular mass 3000 Da. The results pre- before stimulation with LPS (0.1 g/ml). TNF- (A) and PGE2 (B) concen-
sented in Fig. 10 show that cyclooxygenase inhibitors did not alter trations in the J774A.1 culture medium were assayed after 24-h culture as
TNF- release in cocultures of day 1 wound cells and J774A.1 described in Materials and Methods. J774A.1/wound cell cocultures accumu-
macrophages. Neither the selective cyclooxygenase-2 inhibitor lated less TNF- than J774A.1 cultures (p 0.05, by two-factor ANOVA).
NS398 (10 M), nor the nonselective cyclooxygenase inhibitor Neither cyclooxygenase inhibitor had an effect on TNF- release.
The Journal of Immunology
The use of PG receptor antagonists confirmed that PGE2 is not
the inhibitory factor under study. Neither the EP4 PG receptor
antagonist L161982 (0.510 M) nor the EP1/EP2/DP PG receptor
antagonist AH6809 (0.110 M) reversed the inhibition of TNF-
release by LPS-stimulated J774A.1 macrophages cultured with
wound cell-conditioned supernatants (data not shown).
Stimulation of adenosine receptors has been reported to inhibit
the production of TNF- by LPS-stimulated macrophages. No
ATP, ADP, AMP, or adenosine was detected in wound cell-con-
ditioned supernatant by HPLC. To rule out adenosine receptor ac-
tivation by concentrations of adenosine lower than the limit of
detection of the assay, wound cell-conditioned supernatants were
treated with adenosine deaminase before addition to J774A.1 cells.
Adenosine deaminase did not reverse the inhibition of TNF- re-
lease by LPS-stimulated J774A.1 macrophages. Furthermore, the
adenosine receptor antagonist, 8-phenyl theophylline (120 M),
had no effect on TNF- release by LPS-stimulated J774A.1 mac-
rophages (data not shown).
Discussion
The results reported in this study provide in vivo and in vitro
evidence that neutrophils modulate macrophage inflammatory phe-
notype through the release of a soluble mediator(s). In vivo find-
ings in a model of acute sterile inflammation demonstrate that
neutrophil depletion results in selective alterations in local cyto-
kine concentrations that include increases in TNF- and IL-6 and
reduction in TGF-1. Intracellular staining evidenced increased
TNF- staining in both neutrophils and macrophages from the
wounds of neutropenic animals compared with those from control
animals. The observed increases in TNF- and IL-6 in the wound
fluid of neutropenic animals reflect a local, rather than a systemic,
effect, because plasma TNF- and IL-6 were not different in neu-
tropenic and control animals. Moreover, intracellular staining of
TNF- in circulating leukocytes revealed no differences between
the groups.
The increases in TNF- and IL-6 concentrations of wound fluids
from neutropenic animals were unexpected in view of the 67-fold
reduction in the number of total wound leukocytes. The reciprocal
changes in cell number vs proinflammatory cytokine content in the
wounds of control and neutropenic animals suggested that cell
density-dependent mechanisms regulate proinflammatory cytokine
production at sites of inflammation, with a higher cell number
correlating to decreased, rather than increased, cytokine levels.
One well-described mechanism that could account for the present
findings in vivo is the phagocytosis of apoptotic neutrophils and
the subsequent reduction in proinflammatory cytokine release by
macrophages at the inflammatory site (14, 15). Alternatively, the
present observations could be explained by a soluble factor(s) re-
leased from wound cells that down-regulates local proinflamma-
tory cytokine release through an autocrine and/or paracrine mech-
anism. To test for both mechanisms simultaneously, a coculture
system that mimicked the cellularity of the early wound and pre-
vented direct cell-to-cell contact was used.
The data in Fig. 4 show results from one such coculture exper-
iment and demonstrate that day 1 wound cells from naive animals,
which are predominantly neutrophils, inhibited TNF- and IL-6
release by LPS-stimulated J774A.1 macrophages by 60%. The re-
sults depicted in Fig. 5 suggest synthesis and release of the inhib-
itory factor(s) into the medium during coculture, because TNF-
accumulation in the medium was not suppressed until after 8 h in
coculture. Inhibition of TNF- release was detectable by 1 h after
the addition of conditioned supernatant to J774A.1 cells (Fig. 7),
suggesting that those supernatants contain a preformed inhibitory
factor(s). Fig. 6 provides evidence that neutrophils are, among
2271
wound cells, the most likely source for the soluble mediator(s) that
inhibited macrophage cytokine release in cocultures, because cell
culture supernatants from purified wound neutrophils suppressed
TNF- release by LPS-stimulated J774A.1 macrophages to the
same extent as supernatants from unfractionated wound cells.
Moreover, the inhibition of proinflammatory cytokine release is
not due to a nonselective inhibition of protein synthesis, because
total protein synthesis was not altered by wound cell-conditioned
supernatants.
The suppressive effects of wound cell culture supernatants were
not limited to the J774A.1 macrophage cell line. Fig. 8A demon-
strates that the supernatants also inhibited TNF- release from
primary peritoneal macrophages. Moreover, the suppression of
LPS-mediated macrophage activation was not restricted to the pro-
duction of proinflammatory cytokines. The results shown in Fig.
8B illustrate the reduction in macrophage superoxide release that
resulted from culture in wound cell-conditioned supernatant.
Results from this study demonstrate that neutrophils mediate the
inhibition of proinflammatory cytokine and superoxide release
Downloaded from http://www.jimmunol.org/ by guest on December 11, 2017
from macrophages via a soluble mediator(s) of 3000 Da. Char-
acterization of the inhibitory molecule(s) is not yet complete.
Known inhibitors of macrophage TNF- release that are 3000
Da include PGE2 and adenosine. The early accumulation of PGs at
inflammatory sites (16) and the suppressive effects of PGE2 on
macrophage TNF- production (9) suggested that cyclooxygenase
products might mediate wound neutrophil suppression of macro-
phage TNF- release in response to LPS. However, the data in Fig.
10 show that inhibition of PGE2 synthesis by NS 398 or indometh-
acin did not alter the neutrophil-mediated inhibition of TNF- re-
lease by LPS-stimulated macrophages. Also, neither the EP4 re-
ceptor antagonist L161982 nor the EP2 receptor antagonist
AH6809 affected the capacity of wound cell-conditioned superna-
tants to inhibit TNF- release by J774A.1 macrophages. In this
regard the receptor antagonists were selected because J774A.1
cells express only PG receptors of the EP4 and EP2 subtypes (17).
PGE2, therefore, is not the mediator of wound cell suppression of
TNF- release by LPS-stimulated macrophages. Adenosine and
adenosine receptor agonists also inhibit macrophage inflammatory
responses, including the release of TNF- (10 13). Neither aden-
osine nor its metabolic precursors (ATP, ADP, and AMP) were
found in wound cell-conditioned supernatants. Also, the lack of
effect of adenosine deaminase or an adenosine receptor antagonist
argues against involvement of the adenosine receptor in the wound
cell-mediated inhibition of TNF- release by LPS-stimulated
macrophages.
Supernatants from wound-derived fibroblasts, but not those
from splenic lymphocytes or from L929 immortalized murine fi-
broblasts, also suppressed LPS-stimulated TNF- release from
J774A.1 cells. Although it is not known whether the suppressive
factor produced by wound fibroblasts is identical with that from
wound neutrophils, it is of interest that other cell types that come
into contact with macrophages within inflammatory sites are also
capable of inhibiting TNF- release.
These results confirm a role for neutrophils in the regulation of
proinflammatory responses by macrophages. This conclusion finds
support and extension in published studies of neutrophil depletion.
Rats made neutropenic with vinblastine and subjected to hemor-
rhagic shock manifested decreased neutrophil sequestration and
increased expression of IL-6 mRNA and CD14 mRNA in the lung
compared with nonneutropenic controls (18). Mice lacking the
transcriptional repressor Gfi1 are severely neutropenic and have
increased lethality and higher plasma levels of TNF-, IL-10, and
IL-1 after LPS administration (19). Macrophages isolated from
neutropenic Gfi1-deficient mice exhibit increased LPS-stimulated
2272
TNF- release. The findings of the present study suggest that
neutropenia in Gfi1-deficient animals resulted in up-regulation of
macrophage cytokine production. The latter conclusion is also
supported by Steinshamns investigation (20) of the TNF- re-
sponse to endotoxin in mice made neutropenic with cyclophosph-
amide, showing increased lethality and increased serum TNF-
concentration compared with control animals after LPS stimula-
tion. A proinflammatory bias in neutropenia has thus been shown
to be independent of species, mechanism of neutropenia, and
stressor imposed upon the animals.
The work reported in this study resulted in an unexpected and
paradoxical finding: that neutrophils, which are considered proto-
typical inflammatory cells, could act as anti-inflammatory cells
through suppression of the macrophage inflammatory phenotype.
The present observations together with reports indicating that neu-
trophils modulate T cell subset selection in candidiasis (21) and
dendritic cell activation in Toxoplasma gondii infection (22), shed
new light on the capacity of neutrophils to regulate multiple cel-
lular immune responses.
As stated in the introduction, the role of neutrophils in sterile
inflammation has not been completely clarified. With specific re-
gard to the role of neutrophils in the healing of wounds, the current
paradigm, which is based on the work of Simpson and Ross (23),
states that neutrophils are dispensable to the repair process, and
that their function in injured tissue is only to contain or eliminate
infection. Only recently has this paradigm been challenged. Dovi
et al. (24) demonstrated accelerated re-epithelialization of skin
wounds in transiently neutropenic mice, without effects on colla-
gen content or tensile strength of the wound. These findings do not
appear to apply to all models of wound healing, because re-epi-
thelialization of oral wounds in guinea pigs was neither accelerated
nor retarded in neutropenic animals (25). Thus, the role of neutro-
phils in repair remains undefined.
The present observations are unlikely to be limited to wounds.
The early inflammatory response in the PVA sponge wound model
is identical with that observed in other models of sterile tissue
injury, with the early development of a neutrophil-rich cellular
infiltrate that is later replaced by a macrophage-predominant infil-
trate. The suppression of the macrophage proinflammatory pheno-
type by neutrophil products is probably common to all acute sterile
inflammatory processes. Characterization of a neutrophil-derived
soluble mediator(s) that suppresses macrophage proinflammatory
phenotype as well as their mechanism of action may provide
opportunities for therapeutic intervention to suppress macro-
phage inflammatory phenotype, especially during spontaneous
or therapy-induced neutropenia.
Acknowledgments
We thank Jill Rose for assistance in preparing the manuscript.
References
1. Meszaros, A. J., J. S. Reichner, and J. E. Albina. 1999. Macrophage phagocytosis
of wound neutrophils. J. Leukocyte Biol. 65:35.
NEUTROPHIL PRODUCT(S) MODULATE MACROPHAGE PHENOTYPE
2. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival:
application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55.
3. Korzeniewski, C., and D. M. Callewaert. 1983. An enzyme-release assay for
natural cytotoxicity. J. Immunol. Methods 64:313.
4. Ayala, A., Z. K. Deol, D. L. Lehman, C. D. Herdon, and I. H. Chaudry. 1994.
Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased
splenocyte IL-2/IFN- release while increasing IL-4/IL-10 production. J. Surg.
Res. 56:579.
5. Micheli, V., H. A. Simmonds, M. Bari, and G. Pompucci. 1993. HPLC determi-
nation of oxidized and reduced pyridine coenzymes in human erythrocytes. Clin.
Chim. Acta 220:1.
6. Cui, S., J. S. Reichner, R. B. Mateo, and J. E. Albina. 1994. Activated murine
macrophages induce apoptosis in tumor cells through nitric oxide-dependent or
-independent mechanisms. Cancer Res. 54:2462.
7. Nessel, C. C., W. L. Henry, Jr., B. Mastrofrancesco, J. S. Reichner, and
J. E. Albina. 1999. Vestigial respiratory burst activity in wound macrophages.
Am. J. Physiol. 276:R1587.
8. Rabinowitz, S. S., and S. Gordon. 1991. Macrosialin, a macrophage-restricted
membrane sialoprotein differentially glycosylated in response to inflammatory
stimuli. J. Exp. Med. 174:827.
9. Kunkel, S. L., M. Spengler, M. A. May, R. Spengler, J. Larrick, and D. Remick.
1988. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene
expression. J. Biol. Chem. 263:5380.
10. Hasko, G., C. Szabo, Z. H. Nemeth, V. Kvetan, S. M. Pastores, and E. S. Vizi.
1996. Adenosine receptor agonists differentially regulate IL-10, TNF-, and ni-
tric oxide production in RAW 264.7 macrophages and in endotoxemic mice.
Downloaded from http://www.jimmunol.org/ by guest on December 11, 2017
J. Immunol. 157:4634.
11. Hasko, G., D. G. Kuhel, J. F. Chen, M. A. Schwarzschild, E. A. Deitch,
J. G. Mabley, A. Marton, and C. Szabo. 2000. Adenosine inhibits IL-12 and
TNF- production via adenosine A2a receptor-dependent and independent mech-
anisms. FASEB J. 14:2065.
12. McWhinney, C. D., M. W. Dudley, T. L. Bowlin, N. P. Peet, L. Schook,
M. Bradshaw, M. De, D. R. Borcherding, and C. K. Edwards III. 1996. Activation
of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-. Eur.
J. Pharmacol. 310:209.
13. Sajjadi, F. G., K. Takabayashi, A. C. Foster, R. C. Domingo, and G. S. Firestein.
1996. Inhibition of TNF- expression by adenosine: role of A3 adenosine recep-
tors. J. Immunol. 156:3435.
14. Fadok, V. A., D. L. Bratton, A. Konowal, P. W. Freed, J. Y. Westcott, and
P. M. Henson. 1998. Macrophages that have ingested apoptotic cells in vitro
inhibit proinflammatory cytokine production through autocrine/paracrine mech-
anisms involving TGF-, PGE2, and PAF. J. Clin. Invest. 101:890.
15. Murai, N., K. Nagai, H. Fujisawa, K. Hatanaka, M. Kawamura, and Y. Harada.
2003. Concurrent evolution and resolution in an acute inflammatory model of rat
carrageenin-induced pleurisy. J. Leukocyte Biol. 73:456.
16. Gilroy, D. W., P. R. Colville-Nash, D. Willis, J. Chivers, M. J. Paul-Clark, and
D. A. Willoughby. 1999. Inducible cyclooxygenase may have anti-inflammatory
properties. Nat. Med. 5:698.
17. Katsuyama, M., R. Ikegami, H. Karahashi, F. Amano, Y. Sugimoto, and
A. Ichikawa. 1998. Characterization of the LPS-stimulated expression of EP2 and
EP4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1. Bio-
chem. Biophys. Res. Commun. 251:727.
18. Omert, L., K. Tsukada, C. Hierholzer, V. A. Lyons, T. M. Carlos, A. B. Peitzman,
and T. R. Billiar. 1998. A role of neutrophils in the down-regulation of IL-6 and
CD14 following hemorrhagic shock. Shock 9:391.
19. Karsunky, H., H. Zeng, T. Schmidt, B. Zevnik, R. Kluge, K. W. Schmid, U.
Duhrsen, and T. Moroy. 2002. Inflammatory reactions and severe neutropenia in
mice lacking the transcriptional repressor Gfi1. Nat. Genet. 30:295.
20. Steinshamn, S., M. H. Bemelmans, W. A. Buurman, and A. Waage. 1995. Gran-
ulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimu-
lated mice: a possible mechanism of enhanced TNF activity. Cytokine 7:50.
21. Romani, L., A. Mencacci, E. Cenci, G. Del Sero, F. Bistoni, and P. Puccetti.
1997. An immunoregulatory role for neutrophils in CD4 T helper subset selec-
tion in mice with candidiasis. J. Immunol. 158:2356.
22. Bennouna, S., S. K. Bliss, T. J. Curiel, and E. Y. Denkers. 2003. Cross-talk in the
innate immune system: neutrophils instruct recruitment and activation of den-
dritic cells during microbial infection. J. Immunol. 171:6052.
23. Simpson, D. M., and R. Ross. 1972. The neutrophilic leukocyte in wound repair.
J. Clin. Invest. 51:2009.
24. Dovi, J. V., L.-K. He, and L. A. DiPietro. 2003. Accelerated wound closure in
neutrophil-depleted mice. J. Leukocyte Biol. 73:448.
25. Andersen, L., R. Attstrom, and O. Fejerskov. 1978. Effect of experimental neu-
tropenia on oral wound healing in guinea pigs. Scand. J. Dent. Res. 86:237.